Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges
Endothelial progenitor cells (EPCs) are currently being studied as candidate cell sources for revascularization strategies. Significant advances have been made in understanding the biology of EPCs, and preclinical studies have demonstrated the vasculogenic, angiogenic, and beneficial paracrine effec...
Saved in:
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/80629 http://hdl.handle.net/10220/40560 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-80629 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-806292023-12-29T06:46:35Z Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges Chong, Mark Seow Khoon Ng, Wei Kai Chan, Jerry Kok Yen School of Chemical and Biomedical Engineering Endothelial cell Clinical translation Tissue regeneration Endothelial progenitor cells (EPCs) are currently being studied as candidate cell sources for revascularization strategies. Significant advances have been made in understanding the biology of EPCs, and preclinical studies have demonstrated the vasculogenic, angiogenic, and beneficial paracrine effects of transplanted EPCs in the treatment of ischemic diseases. Despite these promising results, widespread clinical acceptance of EPCs for clinical therapies remains hampered by several challenges. The present study provides a concise summary of the different EPC populations being studied for ischemic therapies and their known roles in the healing of ischemic tissues. The challenges and issues surrounding the use of EPCs and the current strategies being developed to improve the harvest efficiency and functionality of EPCs for application in regenerative medicine are discussed. NMRC (Natl Medical Research Council, S’pore) Accepted version 2016-05-20T08:58:49Z 2019-12-06T13:53:30Z 2016-05-20T08:58:49Z 2019-12-06T13:53:30Z 2016 Journal Article Chong, M. S. K., Ng, W. K., & Chan, J. K. Y. (2016). Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges. Stem Cells Translational Medicine, 5(4), 530-538. 2157-6564 https://hdl.handle.net/10356/80629 http://hdl.handle.net/10220/40560 10.5966/sctm.2015-0227 26956207 en Stem Cells Translational Medicine © 2016 AlphaMed Press. This is the author created version of a work that has been peer reviewed and accepted for publication by Stem Cells Translational Medicine, AlphaMed Press. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [10.5966/sctm.2015-0227]. 25 p. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Endothelial cell Clinical translation Tissue regeneration |
spellingShingle |
Endothelial cell Clinical translation Tissue regeneration Chong, Mark Seow Khoon Ng, Wei Kai Chan, Jerry Kok Yen Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges |
description |
Endothelial progenitor cells (EPCs) are currently being studied as candidate cell sources for revascularization strategies. Significant advances have been made in understanding the biology of EPCs, and preclinical studies have demonstrated the vasculogenic, angiogenic, and beneficial paracrine effects of transplanted EPCs in the treatment of ischemic diseases. Despite these promising results, widespread clinical acceptance of EPCs for clinical therapies remains hampered by several challenges. The present study provides a concise summary of the different EPC populations being studied for ischemic therapies and their known roles in the healing of ischemic tissues. The challenges and issues surrounding the use of EPCs and the current strategies being developed to improve the harvest efficiency and functionality of EPCs for application in regenerative medicine are discussed. |
author2 |
School of Chemical and Biomedical Engineering |
author_facet |
School of Chemical and Biomedical Engineering Chong, Mark Seow Khoon Ng, Wei Kai Chan, Jerry Kok Yen |
format |
Article |
author |
Chong, Mark Seow Khoon Ng, Wei Kai Chan, Jerry Kok Yen |
author_sort |
Chong, Mark Seow Khoon |
title |
Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges |
title_short |
Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges |
title_full |
Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges |
title_fullStr |
Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges |
title_full_unstemmed |
Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges |
title_sort |
concise review: endothelial progenitor cells in regenerative medicine: applications and challenges |
publishDate |
2016 |
url |
https://hdl.handle.net/10356/80629 http://hdl.handle.net/10220/40560 |
_version_ |
1787136491884904448 |